News

Antimicrobial resistance seen in multidrug-resistant tuberculosis (MDR-TB) is one of the world’s most serious public health threats. MDR-TB is resistant to at least two of the four most

At the time of analysis, the median duration of response had not been reached with three of five responders on therapy for 11 months or more (range, 15

The Manocept platform serves as the molecular backbone of Navidea’s FDA-approved, activated macrophage-targeting agent, Lymphoseek (technetium Tc 99m tilmanocept) injection. Preclinical data being developed by the Company using

AllStar Health Brands has already received two initial Purchase Orders (POs) from the TapouT gyms. The purchase orders are for the TapouT Muscle Recovery, Topical Pain, TapouT Turbo

The world’s second leading infectious cause of blindness, river blindness is a neglected tropical disease caused by a filarial worm. Emodepside originates from the Japanese pharmaceutical company Astellas

The Company has spent months in resources to locate quality organic CBD oil, toxin and heavy metal free, for the US market. We are pleased that we have

BTI-320 is a non-systemic chewable complex carbohydrate-based compound developed to reduce post-meal elevation of blood glucose. The trial’s primary endpoints are the mean change in Hemoglobin A1c (or

The new production facility will more than double the company’s existing manufacturing capacity in a facility design. The company offers clinical and commercial manufacturing services under cGMP for

Recombinant Nematode Anticoagulation Protein c2 (rNAPc2) has previously showed post-exposure efficacy in non-human primate models of Ebola hemorrhagic fever virus (HFV) and it was originally developed as a